At lower concentrations, MRS-L3 CFS significantly inhibited IL-6 increase after infection (p < 0.05 for MRS-L3 CFS 10%, and p < 0.01 for 5%, compared to the infection control; Figure 4f). This evidence concerns the gene IL6 and infection.